# Imaging in Percutaneous Coronary Intervention

**Authors:** Mohan Satish, Anastasios Roumeliotis, David Power, Anton Camaj, Johny Nicolas, Daniel Feldman, Davis Jones, Keisuke Yasumura, Frans Beerkens, Saman Suleman, George Dangas

PMC · DOI: 10.31083/j.rcm2306204 · Reviews in Cardiovascular Medicine · 2022-05-31

## TL;DR

This review discusses how imaging during heart procedures can improve outcomes, especially for high-risk patients, and summarizes current evidence and techniques.

## Contribution

The paper provides a contemporary review of intracoronary imaging use in PCI, highlighting its benefits and current applications.

## Key findings

- ICI improves cardiovascular outcomes, especially in high-risk subgroups.
- Available ICI modalities include intravascular ultrasound and optical coherence tomography.
- ICI helps in lesion identification and stent placement optimization.

## Abstract

Intracoronary imaging (ICI) use during percutaneous coronary intervention (PCI) 
has been shown to effectively improve cardiovascular outcomes, particularly for 
high-risk subgroups. However, data from randomized controlled trials are limited 
and the overall utilization rate of ICI remains variable between different 
countries and centers. Potential benefits of ICI include identification of 
appropriate lesions for PCI, improved characterization of lesions, and 
optimization of stent placement. Currently available modalities of ICI include 
intravascular ultrasound, optical coherence tomography and near infrared 
spectroscopy. Within this review, we summarize the contemporary evidence 
surrounding ICI and discuss its application in clinical practice.

## Full-text entities

- **Diseases:** Coronary  Bifurcation Lesions (MESH:D003327), nephropathy (MESH:D007674), inflammation (MESH:D007249), coronary artery disease (MESH:D003324), CTOs (MESH:D001157), ischemic complications (MESH:D017202), MI (MESH:D009203), renally (MESH:D006030), spasms (MESH:D013035), fibroatheroma (MESH:D058226), necrotic (MESH:D009336), stent fracture (MESH:D050723), LM disease (MESH:D004194), ICI (MESH:C564543), coronary stenosis (MESH:D023921), ischemic (MESH:D002545), MSA (MESH:C537381), Tissue prolapse (MESH:D011391), TLR (MESH:D009059), stenosis (MESH:D003251), Lipid-Rich Plaque (MESH:D011017), CKD (MESH:D051436), stent  thrombosis (MESH:D013927), Failure (MESH:D051437), long lesions (MESH:D000094024), restenosis (MESH:D023903), calcified plaque (MESH:D003773)
- **Chemicals:** calcium (MESH:D002118), BMS (-), lipid (MESH:D008055)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11273985/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11273985/full.md

## References

101 references — full list in the complete paper: https://tomesphere.com/paper/PMC11273985/full.md

---
Source: https://tomesphere.com/paper/PMC11273985